Clinical Trial Update: DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a dendritic cell vaccine in combination with cytokine-induced killer cells for renal cancer; recruitment has not started yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Cytokine-induced killer cells
• Dendritic cell vaccine

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Renal Neoplasma | Phase 2 | Status: NOT_YET_RECRUITING